Gemcitabine in Ovarian Cancer
Clinical trial NCT00191334 · COMPLETED
Trial details
- NCT number
- NCT00191334
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-12-01
- Primary completion
- 2007-12-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.